![]() Mesoblast Mesoblast specializes in the development of biologic products for the broad field of regenerative medicine. | Harmony Biosciences Harmony Biosciences develops therapies to help patients with unmet medical needs. | Translational Sciences Translational Sciences is a biotechnology company that develops therapeutics for treating acute thrombotic cardiovascular diseases and ischemic stroke. | |
Founding Date | Founding Date 2004 | Founding Date 2017 | Founding Date 2007 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Melbourne, AU HQ Singapore, SG New York, US | Locations Plymouth Meeting, US HQ | Locations Phoenix, US HQ |
Employees | Employees 73 | Employees N/A | Employees N/A |
Valuation ($) | Valuation ($) 1.2 b | Valuation ($) 2.4 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $17.2m (FY, 2025) | Revenue (est.) $868.5m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods $1.2m (FY, 2025) | Cost of goods $198.3m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit $16.1m (FY, 2025) | Gross profit $670.1m (FY, 2025) | Gross profit N/A |
Net income | Net income ($102.1m) (FY, 2025) | Net income $158.7m (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 56.2m | Total funding raised $ 270m | Total funding raised N/A |
Harmony Biosciences develops therapies to help patients with unmet medical needs.
View companyTranslational Sciences is a biotechnology company that develops therapeutics for treating acute thrombotic cardiovascular diseases and ischemic stroke.
View company